BeOne Medicines Ltd. Class A

BeOne Medicines Ltd. Class A - Enterprise Valueverified

688235.SS

Price:

$250.51

Market Cap:

$38.62B

BeOne Medicines AG, an oncology-focused enterprise headquartered in Basel, Switzerland, was established in 2010. This company is actively involved in the exploration and advancement of a diverse range of therapeutic solutions for cancer patients across key global regions, including the United States, China, Europe, and other international markets. Its current commercial portfolio features several significant treatments: BRUKINSA: A small molecule designed to inhibit Bruton's Tyrosine Kinase (BTK), indicated for various blood cancers. TEVIMBRA: An anti-PD-1 antibody immunotherapy utilized in the treatment of both solid tumors and blood cancers. PARTRUVIX: A selective small molecule inhibitor ...[Read more]

Industry

Biotechnology

IPO Date

2021-12-15

Stock Exchange

SHH

Ticker

688235.SS

The Enterprise Value as of July 2026 (TTM) for BeOne Medicines Ltd. Class A (688235.SS) is 35.83B

According to BeOne Medicines Ltd. Class A’s latest financial reports and current stock price. The company's current Enterprise Value is 35.83B. This represents a change of 40.20% compared to the average of 25.55B of the last 4 quarters.

BeOne Medicines Ltd. Class A (688235.SS) Historical Enterprise Value (quarterly & annually)

How has 688235.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of BeOne Medicines Ltd. Class A over the last ten years is 5.33B. The current 35.83B Enterprise Value has changed 67.06% with respect to the historical average. Over the past ten years (40 quarters), 688235.SS's Enterprise Value was at its highest in in the December 2025 quarter at 52.69B. The Enterprise Value was at its lowest in in the June 2022 quarter at -2374613894.94.

Quarterly (TTM)
Annual

Average

5.33B

Median

778.79M

Minimum

-1570817496.85

Maximum

50.95B

BeOne Medicines Ltd. Class A (688235.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BeOne Medicines Ltd. Class A Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 6.48%

Maximum Annual Enterprise Value = 50.95B

Minimum Annual Increase = -503.75%

Minimum Annual Enterprise Value = -1570817496.85

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202550.95B6.48%
2024774.41M-503.75%
2023-191801733.32-85.17%
2022-1293422472.23-17.66%
2021-1570817496.85-226.82%
20201.24B18.23%
20191.05B33.76%
2018783.18M-18.27%
2017958.27M47.54%
2016649.49M203.75%

BeOne Medicines Ltd. Class A (688235.SS) Average Enterprise Value

How has 688235.SS Enterprise Value performed in the past?

The current Enterprise Value of BeOne Medicines Ltd. Class A (688235.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

17.18B

5-year avg

9.73B

10-year avg

5.33B

BeOne Medicines Ltd. Class A (688235.SS) Enterprise Value vs. Peers

How is 688235.SS’s Enterprise Value compared to its peers?

BeOne Medicines Ltd. Class A’s Enterprise Value is less than WuXi AppTec Co., Ltd. (264.06B), less than Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (163.73B), greater than Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (34.11B), greater than Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (31.34B), less than Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (39.21B), less than RemeGen Co. Ltd. Class A (65.17B), less than Shanghai Junshi Biosciences Co., Ltd. (37.81B), greater than Nanjing Vazyme Biotech Co., Ltd. (8.79B), greater than Suzhou Zelgen Biopharmaceuticals Co., Ltd. (33.26B), greater than Sinocelltech Group Limited (19.56B),

Build a custom stock screener for BeOne Medicines Ltd. Class A (688235.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BeOne Medicines Ltd. Class A using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BeOne Medicines Ltd. Class A (688235.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BeOne Medicines Ltd. Class A or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is BeOne Medicines Ltd. Class A's Enterprise Value?

What is the highest Enterprise Value for BeOne Medicines Ltd. Class A (688235.SS)?

What is the 3-year average Enterprise Value for BeOne Medicines Ltd. Class A (688235.SS)?

What is the 5-year average Enterprise Value for BeOne Medicines Ltd. Class A (688235.SS)?

How does the current Enterprise Value for BeOne Medicines Ltd. Class A (688235.SS) compare to its historical average?